Eschler Asset Management LLP Bio N Tech Se Transaction History

Eschler Asset Management LLP

  • $38.8 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$118.43 - $186.05 $537,672 - $844,667
4,540 New
4,540 $681,000
Q2 2022

Aug 15, 2022
BUY
$123.25 - $186.24 $55,462 - $83,808
450 Added 18.37%
2,900 $432,000
Q1 2022

May 16, 2022
BUY
$126.25 - $231.85 $309,312 - $568,032
2,450 New
2,450 $418,000

Others Institutions Holding BNTX

# of Institutions
364
Shares Held
39.6M
Call Options Held
3.01M
Put Options Held
2.01M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $23.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Eschler Asset Management LLP Portfolio

Follow Eschler Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eschler Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Eschler Asset Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email